ClinicalTrials.gg
CompletedNCT05885087Updated Jun 1, 2023

'Extended Balloon Catheter' Labour Induction; a Single Arm Pilot Trial'

An interventional study of Foley or balloon catheter in Labor, Induced, sponsored by University of Botswana. Completed at 1 site in Botswana. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-01.

Sponsored by University of Botswana · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Feb 2022, registered May 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The overall aim of the single arm pilot study was to assess the effectiveness, safety and acceptance of the 'extended balloon catheter' as a method of induction of labour in women receiving care at Princess Marina Hospital(PMH) in Gaborone, Botswana.

The main questions it aimed to answer were whether 'extended balloon catheter' is an effective method of labour induction, whether it results in increased adverse events for the mother and baby and whether it is associated with increased mother satisfaction.

Participants were assessed as having a favourable cervix using the modified Bishop score of equal to or more than 7. Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied. Delivery interval (time of induction to time of delivery), mode of delivery and Apgar scores were recorded. Adverse maternal and neonatal outcomes were recorded. Participants' satisfaction with the method of induction was assessed using a descriptive scale.

Read the detailed description

Labour induction is indicated when the benefits to the mother and/or foetus of discontinuing the pregnancy outweigh the risks of awaiting spontaneous onset of labour. However, induction of labour is not without risk and the World Health Organisation recommends induction of labour be performed with a clear medical indication and when the expected benefits outweigh potential harms. Established indications for induction of labour include gestational age of 41 completed weeks or more, prelabour rupture of amniotic membranes, hypertensive disorders, maternal medical complications, foetal growth restriction, chorioamnionitis, multiple pregnancy, vaginal bleeding and other complications.

The ideal method for induction should be safe for both the mother and baby, cost effective and not require extensive monitoring. Trans-cervical extra-amniotic Foley catheter placement has been shown to be the safest method of labour induction with fewer maternal and neonatal side effects such as uterine hyperstimulation and changes in foetal heart rate during labour than prostaglandins or oxytocin. It has also been shown that there were no significant differences between caesarean and vaginal deliveries between Foley catheter, prostaglandins and oxytocin, although labour was shown to last longer after induction with Foley catheter than with prostaglandins and oxytocin. These factors can therefore potentially influence the women's preference for either method.

Foley catheter has generally been used for labour induction with an unfavourable cervix and once the cervix is favourable or the Foley method is unsuccessful, prostaglandins or oxytocin with amniotomy are used. In lower and middle income countries like Botswana where patient monitoring during induction of labour and labour is limited and mostly intermittent, mainly due to the limited or lack of monitoring devices to detect uterine hyperstimulation or foetal heart rate changes, a high patient to midwife ratio, and a high HIV prevalence, it may be preferable to avoid amniotomy and risks associated with hyperstimulation with exogenous oxytocin or prostaglandins. There are no randomized trials of Foley catheter induction with a favourable cervix reported in the Cochrane review of mechanical methods of labour induction. To optimize the likelihood of delivery without recourse to amniotomy and oxytocin or prostaglandins, 'extended balloon catheter' has been proposed as a method of continuing induction and augmentation with a Foley catheter rather than switching to other methods.

The purpose of this proposed single arm pilot trial was to test this novel idea of using 'extended balloon catheter' for induction of labour in women with favourable cervix in Botswana, and assess its effectiveness, safety to both the mother and baby as well as patient satisfaction with the procedure. Findings from this study will guide clinical protocols on how to utilize the safest available option for optimal maternal and neonatal outcomes as well as offer options and evidence for counselling women for whom prostaglandins or oxytocin are contraindicated or for use with caution in Botswana and elsewhere.

02

Conditions studied

  • Labor, Induced

Keywords

  • foley/balloon catheter
  • labor induction
  • favorable cervix
03

In context

Lead sponsor

University of Botswana is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women 18 years or older without serious morbidity due for labour induction, who give consent to participate.
  • Cervix considered too far dilated to retain a single balloon, or single balloon has fallen out while not yet in labour.
  • Bishop score of equal or more than 7.
  • Nulliparous and multiparous
  • Singleton and cephalic
  • Gestation >37+0 weeks
  • Estimated fetal weight \<4kg

Exclusion criteria

Exclusion Criteria:

  • Previous caesarean delivery
  • Very urgent labour induction indications (eg eclampsia, preeclampsia with severe features)
  • Ruptured membranes
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Foley/Balloon catheter arm

    Participants were assessed as having a favourable cervix using the modified Bishop score of equal to or more than 7. Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied.

    Device: Foley or balloon catheter

Interventions

  • DeviceFoley or balloon catheter

    Three Foley balloon catheters attached side by side were inflated with 60mls each and a gentle traction of 250mls water applied.

06

What researchers measure

Primary outcomes

  1. Successful labor induction

    Successful labor induction defined as vaginal birth within 60 hours.

    Time frame: Enrolment until 60 hours

Secondary outcomes

  1. Adverse event

    Any adverse maternal and fetal outcomes in participants

    Time frame: Enrolment until discharge from hospital, or up to 2 weeks

  2. Acceptability

    Satisfaction with the procedure as defined by postpartum questionnaire

    Time frame: Enrolment until discharge from hospital, or up to 2 weeks

07

Study locations

1 site
  • Princess Marina Hospital
    Gaborone, South East 267, Botswana
08

References and documents

Individual participant data

Plan to share: Yes — Study protocol, consent form and data collection tool.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: within 5 years after study completion.

Access criteria: reasonable request in the context of an approved protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05885087
Lead sponsor
University of Botswana
Responsible party
Lorato Matshitsa (Senior Resident, Department of Obstetrics and Gynecology, University of Botswana) — Principal investigator
First posted
Jun 1, 2023
Start date
Feb 1, 2022
Primary completion
Aug 1, 2022
Completion
Sep 1, 2022
Last update
Jun 1, 2023

Study contacts

JUSTUS HOFMEYR, DSc
study director · University of Botswana

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion